Bisphosphonate-Related Osteonecrosis of Jaws in 3 Osteoporotic Patients With History of Oral Bisphosphonate Use Treated With Single Yearly Zoledronic Acid Infusion

Saved in:

Bibliographic Details
Published in:	Journal of oral and maxillofacial surgery Vol. 70; no. 2; pp. 325 - 330
Main Authors:	Fitzpatrick, Sarah G., DDS, Stavropoulos, Mary F., DDS, Bowers, Leah M., DMD, Neuman, Ashley N., DDS, Hinkson, David W., DDS, Green, James G., DDS, MD, Bhattacharyya, Indraneel, DDS, MSD, Cohen, Donald M., DMD, MS, MBA
Format:	Journal Article
Language:	English
Published:	United States Elsevier Inc 01-02-2012
Subjects:	Aged Alendronate - therapeutic use Bisphosphonate-Associated Osteonecrosis of the Jaw - etiology Bone Density Conservation Agents - administration & dosage Bone Density Conservation Agents - adverse effects Bone Density Conservation Agents - therapeutic use Bone Diseases, Metabolic - drug therapy Dentistry Diphosphonates - administration & dosage Diphosphonates - adverse effects Diphosphonates - therapeutic use Etidronic Acid - analogs & derivatives Etidronic Acid - therapeutic use Female Follow-Up Studies Humans Imidazoles - administration & dosage Imidazoles - adverse effects Infusions, Intravenous Mandibular Diseases - chemically induced Maxillary Diseases - chemically induced Middle Aged Osteoporosis, Postmenopausal - drug therapy Risedronate Sodium Surgery Tooth Extraction - adverse effects Tooth Socket - pathology
Online Access:	Get full text
Tags:	Add Tag No Tags, Be the first to tag this record!

Description
Bibliography:	ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 23
ISSN:	0278-2391 1531-5053
DOI:	10.1016/j.joms.2011.02.049